Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00719901 · TERMINATED
Trial details
- NCT number
- NCT00719901
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2011-04-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.